{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:06:33Z","timestamp":1786118793175,"version":"build-2736575974"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1097\/mco.0b013e3280ebb427","type":"journal-article","created":{"date-parts":[[2007,4,5]],"date-time":"2007-04-05T04:04:40Z","timestamp":1175745880000},"page":"311-317","source":"Crossref","is-referenced-by-count":4,"title":["Stability and compatibility of histamine H2-receptor antagonists in parenteral nutrition mixtures"],"prefix":"10.1097","volume":"10","author":[{"given":"Marko","family":"Puzovic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210204","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0149-2918(04)90019-7","article-title":"Stress-related mucosal disease: risk factors and prophylactic therapy","volume":"26","author":"Spirt","year":"2004","journal-title":"Clin Ther"},{"key":"R2-9-20210204","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/j.1552-4604.1998.tb04443.x","article-title":"Pharmacokinetics and pharmacodynamics of ranitidine in neonates treated with extracorporeal membrane oxygenation","volume":"38","author":"Wells","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"R3-9-20210204","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1097\/00003246-199808000-00032","article-title":"Gastric pH control in critically ill children receiving intravenous ranitidine","volume":"26","author":"Harrison","year":"1998","journal-title":"Crit Care Med"},{"key":"R4-9-20210204","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/BF01211180","article-title":"Control of gastric pH with ranitidine in patients with Crohn's disease receiving total parenteral nutrition: comparison of two intravenous regimens","volume":"31","author":"Matsui","year":"1996","journal-title":"J Gastroenterol"},{"key":"R5-9-20210204","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2165\/00003088-200443140-00001","article-title":"Enteral drug absorption in patients with short small bowel: a review","volume":"43","author":"Severijnen","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R6-9-20210204","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/00075197-200405000-00011","article-title":"Surgical management of high output enterocutaneous fistulae: a 24-year experience","volume":"7","author":"Haffejee","year":"2004","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R7-9-20210204","first-page":"2049","article-title":"Essential therapeutic strategies for acute pancreatitis: guidelines for initial treatment and their significance","volume":"62","author":"Hirata","year":"2004","journal-title":"Jpn J Clin Med"},{"key":"R8-9-20210204","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1093\/ajhp\/62.10_Supplement_2.S11","article-title":"Contemporary strategies for the prevention of stress-related mucosal bleeding","volume":"62","author":"Martindale","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R9-9-20210204","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/ajhp\/62.10_Supplement_2.S4","article-title":"Overview of pharmacologic agents for acid suppression in critically ill patients","volume":"62","author":"Welage","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R10-9-20210204","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1093\/ajhp\/52.10.1082","article-title":"Intravenous histamine H2-receptor antagonists and parenteral nutrition: patterns of use","volume":"52","author":"Bone","year":"1995","journal-title":"Am J Health Syst Pharm"},{"key":"R11-9-20210204","first-page":"104","article-title":"Audit of ranitidine administration in parenteral nutrient solutions","volume":"48","author":"Hershey","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"R12-9-20210204","first-page":"276","article-title":"Parenteral nutrient admixtures as drug vehicles: theory and practice in the critical care setting","volume":"25","author":"Driscoll","year":"1991","journal-title":"DICP Ann Pharmacother"},{"key":"R13-9-20210204","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00000658-198107000-00004","article-title":"Effect of an intravenous infusion of amino acids (Aminoplex 14) on gastric secretion in healthy subjects and patients with duodenal ulcers","volume":"194","author":"Psaila","year":"1981","journal-title":"Ann Surg"},{"key":"R14-9-20210204","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1056\/NEJM197801052980106","article-title":"Intravenous infusion of amino acids stimulates gastric acid secretion in man","volume":"298","author":"Isenberg","year":"1978","journal-title":"N Engl J Med"},{"key":"R15-9-20210204","doi-asserted-by":"crossref","first-page":"G664","DOI":"10.1152\/ajpgi.00096.2005","article-title":"L-type amino acids stimulate gastric acid secretion by activation of the calcium-sensing receptor in parietal cells","volume":"289","author":"Busque","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R16-9-20210204","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2165\/00002018-200124010-00004","article-title":"Nephrotoxicity and hepatotoxicity of histamine H2 receptor antagonists","volume":"24","author":"Fisher","year":"2001","journal-title":"Drug Saf"},{"key":"R17-9-20210204","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.CCM.0000142398.73762.20","article-title":"Prevention of stress ulceration: current trends in critical care","volume":"32","author":"Daley","year":"2004","journal-title":"Crit Care Med"},{"key":"R18-9-20210204","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/j.1440-1746.2006.04323.x","article-title":"Tolerance to H2 receptor antagonist correlates well with the decline in efficacy against gastroesophageal reflux in patients with gastroesophageal reflux disease","volume":"21","author":"Furuta","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R19-9-20210204","first-page":"351","article-title":"Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 h","volume":"94","author":"Netzer","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"R20-9-20210204","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1572-0241.2006.00773.x","article-title":"Continuous infusion of pantoprazole versus ranitidine for prevention of ulcer rebleeding: a U.S. multicenter randomized, double-blind study","volume":"101","author":"Jensen","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"R21-9-20210204","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00004836-200201000-00012","article-title":"The novel use of an intravenous proton pump inhibitor in a patient with short bowel syndrome","volume":"34","author":"Tang","year":"2002","journal-title":"J Clin Gastroenterol"},{"key":"R23-9-20210204","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1111\/j.1572-0241.2001.05362.x","article-title":"Proton pump inhibitors and gastric acid secretion","volume":"96","author":"Wolfe","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R24-9-20210204","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1345\/aph.1G126","article-title":"Proton pump inhibitor formulary considerations in the acutely ill. Part 1: Pharmacology, pharmacodynamics, and available formulations","volume":"39","author":"Devlin","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R25-9-20210204","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1093\/ajhp\/62.10_Supplement_2.S24","article-title":"Proton pump inhibitors for acid suppression in the intensive care unit: formulary considerations","volume":"62","author":"Devlin","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R26-9-20210204","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2362.2005.01543.x","article-title":"Developments in the inhibition of gastric acid secretion","volume":"35","author":"Mossner","year":"2005","journal-title":"Eur J Clin Invest"},{"key":"R27-9-20210204","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.mco.0000165009.24202.64","article-title":"Stability and compatibility assessment techniques for total parenteral nutrition admixtures: setting the bar according to pharmacopeial standards","volume":"8","author":"Driscoll","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R28-9-20210204","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0899-9007(97)00034-8","article-title":"Stability of ranitidine and thiamine in parenteral nutrition solutions","volume":"13","author":"Baumgartner","year":"1997","journal-title":"Nutrition"},{"key":"R29-9-20210204","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0261-5614(95)80016-6","article-title":"Factors influencing the stability of ranitidine in TPN mixtures","volume":"14","author":"Allwood","year":"1995","journal-title":"Clin Nutr"},{"key":"R30-9-20210204","first-page":"32","article-title":"Long-term stability of ranitidine solutions: effects on lipid emulsion stability","volume":"1","author":"Grimble","year":"1991","journal-title":"Br J Intensive Care"},{"key":"R31-9-20210204","first-page":"1574","article-title":"In vitro evaluation of the stability of ranitidine hydrochloride in total parenteral nutrient mixtures","volume":"47","author":"Williams","year":"1990","journal-title":"Am J Hosp Pharm"},{"key":"R32-9-20210204","first-page":"1100","article-title":"Stability of ranitidine hydrochloride in total nutrient admixtures","volume":"45","author":"Cano","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"R33-9-20210204","first-page":"590","article-title":"Stability of ranitidine hydrochloride in total parenteral nutrient solution","volume":"42","author":"Walker","year":"1985","journal-title":"Am J Hosp Pharm"},{"key":"R34-9-20210204","first-page":"2683","article-title":"Stability of ranitidine hydrochloride and amino acids in parenteral nutrient solutions","volume":"42","author":"Bullock","year":"1985","journal-title":"Am J Hosp Pharm"},{"key":"R35-9-20210204","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/014860719401800405","article-title":"Histamine receptor antagonists and lipid stability in total nutrient admixtures","volume":"18","author":"Hatton","year":"1994","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R36-9-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(03)00067-X","article-title":"Stability of ranitidine in injectable solutions","volume":"256","author":"Vehabovic","year":"2003","journal-title":"Int J Pharm"},{"key":"R37-9-20210204","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1039\/p19870000951","article-title":"Isolation and identification of the hydrolytic degradation products of ranitidine hydrochloride","volume":"11","author":"Haywood","year":"1987","journal-title":"J Chem Soc, Perkin trans, I"},{"key":"R38-9-20210204","first-page":"357","article-title":"Drug interactions of H2-receptor antagonists involving cytochrome P450 (CYPs) enzymes: from the laboratory to the clinic","volume":"40","author":"Rendic","year":"1999","journal-title":"Croat Med J"},{"key":"R39-9-20210204","first-page":"349","article-title":"The dissolved oxygen content of parenteral nutrition admixtures prepared by different methods","volume":"2","author":"Ball","year":"1996","journal-title":"Pharmaceutical Sciences"},{"key":"R40-9-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/00075197-199805000-00010","article-title":"Basic principles for compounding all-in-one parenteral nutrition admixtures","volume":"1","author":"Hardy","year":"1998","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R41-9-20210204","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/01.mco.0000165008.47073.ba","article-title":"Practical aspects of multichamber bags for total parenteral nutrition","volume":"8","author":"Muhlebach","year":"2005","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"R42-9-20210204","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0899-9007(96)00035-4","article-title":"Effects of air and oxygen on parenteral nutrition admixtures: an underrated risk?","volume":"12","author":"Allwood","year":"1996","journal-title":"Nutrition"},{"key":"R43-9-20210204","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/0261-5614(92)90005-B","article-title":"The stability of ascorbic acid in TPN mixtures stored in a multilayered bag","volume":"11","author":"Allwood","year":"1992","journal-title":"Clin Nutr"},{"key":"R44-9-20210204","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1177\/014860710402800285","article-title":"Effects of multilayered bags vs ethylvinyl-acetate bags on oxidation of parenteral nutrition","volume":"28","author":"Balet","year":"2004","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R45-9-20210204","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/jps.2600820611","article-title":"Effects of temperature and relative humidity on the solid-state chemical stability of ranitidine hydrochloride","volume":"82","author":"Teraoka","year":"1993","journal-title":"J Pharm Sci"},{"key":"R46-9-20210204","first-page":"2384","article-title":"Comment on stability of ranitidine hydrochloride in total nutrient admixtures","volume":"48","author":"Montoro","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"R48-9-20210204","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/ajhp\/54.11.1295","article-title":"Compatibility of parenteral nutrient solutions with selected drugs during simulated Y-site administration","volume":"54","author":"Trissel","year":"1997","journal-title":"Am J Health Syst Pharm"},{"key":"R49-9-20210204","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/014860719902300267","article-title":"Compatibility of medications with 3-in-1 parenteral nutrition admixtures","volume":"23","author":"Trissel","year":"1999","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R50-9-20210204","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.nut.2005.09.001","article-title":"Beyond the bag horizon","volume":"21","author":"Hardy","year":"2005","journal-title":"Nutrition"},{"key":"R51-9-20210204","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1093\/ajhp\/53.21.2611","article-title":"Compatibility of neonatal parenteral nutrient solutions with selected intravenous drugs","volume":"53","author":"Veltri","year":"1996","journal-title":"Am J Health Syst Pharm"},{"key":"R52-9-20210204","first-page":"390","article-title":"Cimetidine hydrochloride compatibility. I: Chemical aspects and room temperature stability in intravenous infusion fluids","volume":"37","author":"Rosenberg","year":"1980","journal-title":"Am J Hosp Pharm"},{"key":"R53-9-20210204","first-page":"484","article-title":"Stability of cimetidine hydrochloride in parenteral nutrition solutions","volume":"39","author":"Tsallas","year":"1982","journal-title":"Am J Hosp Pharm"},{"key":"R54-9-20210204","first-page":"2208","article-title":"Stability of cimetidine hydrochloride in a total nutrient admixture","volume":"42","author":"Baptista","year":"1985","journal-title":"Am J Hosp Pharm"},{"key":"R55-9-20210204","first-page":"429","article-title":"Stability of cimetidine HCl and copper sulfate in a TPN solution","volume":"23","author":"Mitrano","year":"1989","journal-title":"DICP Ann Pharmacother"},{"key":"R56-9-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1365-2710.1996.tb00343.x","article-title":"Long-term stability of cimetidine in total parenteral nutrition","volume":"21","author":"Allwood","year":"1996","journal-title":"J Clin Pharm Ther"},{"key":"R57-9-20210204","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/014860718100500161","article-title":"Cimetidine and parenteral nutrition","volume":"5","author":"Moore","year":"1981","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R58-9-20210204","first-page":"1321","article-title":"Cost-effectiveness of parenteral nutrient solutions containing cimetidine hydrochloride","volume":"41","author":"Mu-Chow","year":"1984","journal-title":"Am J Hosp Pharm"},{"key":"R59-9-20210204","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/106002809302700221","article-title":"Change in prescribing patterns of intravenous histamine2-receptor antagonists results in significant cost savings without adversely affecting patient-care","volume":"27","author":"Fudge","year":"1993","journal-title":"Ann Pharmacother"},{"key":"R60-9-20210204","first-page":"132","article-title":"Stability of famotidine in minibags refrigerated and\/or frozen","volume":"23","author":"Bullock","year":"1989","journal-title":"DICP Ann Pharmacother"},{"key":"R61-9-20210204","first-page":"S44","article-title":"Stability of famotidine in minibags refrigerated and\/or frozen in total parenteral nutrition solutions","volume":"23","author":"Bullock","year":"1989","journal-title":"DICP Ann Pharmacother"},{"key":"R62-9-20210204","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/106002809302700404","article-title":"Stability of famotidine in polyvinyl chloride minibags and polypropylene syringes and compatibility of famotidine with selected drugs","volume":"27","author":"Keyi","year":"1993","journal-title":"Ann Pharmacother"},{"key":"R63-9-20210204","first-page":"2321","article-title":"Stability of famotidine 20 and 40 mg\/L and amino acids in total parenteral nutrient solutions","volume":"46","author":"Bullock","year":"1989","journal-title":"Am J Hosp Pharm"},{"key":"R64-9-20210204","first-page":"1507","article-title":"Stability of nizatidine in total nutrient admixtures","volume":"48","author":"Hatton","year":"1991","journal-title":"Am J Hosp Pharm"},{"key":"R65-9-20210204","first-page":"1523","article-title":"Stability of nizatidine in commonly used intravenous fluids and containers","volume":"45","author":"Raineri","year":"1988","journal-title":"Am J Hosp Pharm"},{"key":"R66-9-20210204","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajhp\/62.3.289","article-title":"Stability of roxatidine acetate in parenteral nutrient solutions containing different amino acid formulations","volume":"62","author":"Oh","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"R67-9-20210204","first-page":"1547","article-title":"Implementing therapeutic interchange of intravenous famotidine for cimetidine and ranitidine","volume":"47","author":"Oh","year":"1990","journal-title":"Am J Hosp Pharm"},{"key":"R68-9-20210204","first-page":"39","article-title":"Drug\u2013nutrient considerations in patients receiving parenteral and enteral nutrition","volume":"19","author":"Sacks","year":"2004","journal-title":"Practical Gastroenterology"}],"container-title":["Current Opinion in Clinical Nutrition & Metabolic Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MCO.0b013e3280ebb427","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:36:14Z","timestamp":1786034174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00075197-200705000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":66,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/mco.0b013e3280ebb427","relation":{},"ISSN":["1363-1950"],"issn-type":[{"value":"1363-1950","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}